Literature DB >> 11174630

KL-6 is a potential marker for interstitial lung disease associated with juvenile dermatomyositis.

I Kobayashi1, S Ono, N Kawamura, M Okano, K Miyazawa, H Shibuya, K Kobayashi.   

Abstract

Serum levels of KL-6 were examined in 8 cases of juvenile dermatomyositis: 3 with interstitial lung disease (ILD) and 5 without ILD. The KL-6 levels were elevated in the ILD cases and correlated with the degree of computed tomography findings. The measurement of serum KL-6 levels is useful for evaluating juvenile dermatomyositis-associated ILD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11174630     DOI: 10.1067/mpd.2001.110324

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  6 in total

Review 1.  Immunological biomarkers in dermatomyositis.

Authors:  Jeannette M Olazagasti; Timothy B Niewold; Ann M Reed
Journal:  Curr Rheumatol Rep       Date:  2015-11       Impact factor: 4.592

Review 2.  Serum biomarkers in interstitial lung diseases.

Authors:  Argyris Tzouvelekis; George Kouliatsis; Stavros Anevlavis; Demosthenes Bouros
Journal:  Respir Res       Date:  2005-07-21

Review 3.  Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools.

Authors:  Judith Wienke; Claire T Deakin; Lucy R Wedderburn; Femke van Wijk; Annet van Royen-Kerkhof
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

Review 4.  Review: Serum Biomarkers of Lung Fibrosis in Interstitial Pneumonia with Autoimmune Features-What Do We Already Know?

Authors:  Ewa Miądlikowska; Patrycja Rzepka-Wrona; Joanna Miłkowska-Dymanowska; Adam Jerzy Białas; Wojciech Jerzy Piotrowski
Journal:  J Clin Med       Date:  2021-12-24       Impact factor: 4.241

Review 5.  Respiratory symptoms as initial manifestations of interstitial lung disease in clinically amyopathic juvenile dermatomyositis: a case report with literature review.

Authors:  Jingyi Xia; Gaoli Jiang; Tingting Jin; Quanli Shen; Yangyang Ma; Libo Wang; Liling Qian
Journal:  BMC Pediatr       Date:  2021-11-03       Impact factor: 2.125

6.  Predicting the severity of acute bronchiolitis in infants: should we use a clinical score or a biomarker?

Authors:  Flore Amat; Cécile Henquell; Matthieu Verdan; Laurence Roszyk; Aurélien Mulliez; André Labbé
Journal:  J Med Virol       Date:  2013-12-27       Impact factor: 2.327

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.